Approach to the Management and Treatment of Women With Dysmenorrhea
Keywords:
algodysmenorrhea, chronic pelvic pain syndrome, combined oral contraceptives, nonsteroidal anti-inflammatory drugsAbstract
The presence of persistent pain syndrome leads to disorders of mental and physical health, being the cause of temporary and persistent loss of working capacity. Purpose of the study: assessment of pain syndrome and psychoemotional state of women suffering from algodysmenorrhea. The examined were divided into groups: in the 1st group the treatment with NSAIDs was carried out, in the 2nd group NSAIDs and combined oral contraceptives were used. And so, pelvic pain syndrome is represented by gynecologic pathology with a small morphofunctional manifestation, autonomic disturbance and psychoemotional disorder. The main principle of dysmenorrhea treatment is aimed at normalization of menstrual cycle and reduction of prostaglandins production, and the treatment should be personalized.
References
Buralkina N.A., Batyrova Z.K., Kumykova Z.H. Possibilities of primary dysmenorrhea therapy in young women. A clinical case. Gynecology. 2021; 23 (3): 267-269.
Isenova S.Sh., Saparalieva A.M., Abdykalykova B.I. Modern view on epidemiology, medical and social significance, causes and mechanism of dysmenorrhea development (literature review). Bulletin of the Kazakh National Medical University. 2020; 2: 18-23.
Lebedev V.A., Pashkov V.M., Ignatko I.V., Kuzmina T.E. The choice of a method of therapy for primary dysmenorrhea. A difficult patient. 2020; 1–2.
Acheampong K., Baffour-Awuah D., Ganu D., et al. Prevalence and predictors of dysmenorrhea, its effect, and coping mechanisms among adolescents in Shai Osudoku District, Ghana. Obstet. Gynecol. Int. 2019; 2019: 5834159.
Arafa A., Saleh L., Shawky S. Association between menstrual disorders and school absenteeism among schoolgirls in South Egypt. Int. J. Adolesc. Med. Health. 2019; 34 (1).
Duman N.B., Yıldırım F., Vural G. Risk factors for primary dysmenorrhea and the effect of complementary and alternative treatment methods: sample from Corum, Turkey. Int. J. Health Sci. (Qassim). 2022; 16 (3): 35–43.
Feng X., Wang X. Comparison of the efficacy and safety of non-steroidal anti-inflammatory drugs for patients with primary dysmenorrhea: a network meta-analysis. Mol. Pain. 2018; 14: 1744806918770320.
Ferries-Rowe E., Corey E., Archer J.S. Primary dysmenorrhea: diagnosis and therapy. Obstet. Gynecol. 2020; 136 (5): 1047–1058.
Lin S.Y., Yang Y.C., Lin C.C., et al. increased incidence of dysmenorrhea in women exposed to higher concentrations of NO, NO2, NOx, CO, and PM2.5: a nationwide population-based study. Front. Public Health. 2021; 9: 682341.
Naaz M., Sabuwala J., Naaz A., et al. Role of monteleukast in dysmennorhoea world. J. Pharmac. Med. Res. 2020; 6 (11): 66–72.
Takata K., Kotani K., Umino H. The relationship between body mass index and dysmenorrhea in the general female population. J. Clin. Med. Res. 2023; 15 (4): 239–242.
